This resolution supports designating March 21, 2026, as National Women in Agriculture Day to recognize the contributions of women in the agricultural sector. It highlights that over 1.2 million women in the U.S. are agricultural producers, representing more than one-third of all producers, and notes their significant economic impact through farm sales and roles in research, education, and agribusiness. The measure encourages citizens to acknowledge and celebrate women working in agriculture during National Ag Week, aligning with the 2026 International Year of the Woman Farmer.
S 2903, the Safe Step Act, requires health insurance plans and employers offering health coverage to establish a clear, timely process for patients or doctors to request exceptions when step therapy protocols (where insurers require trying cheaper drugs first) would harm a patient. It mandates approval for exceptions if prior drugs failed, delay would cause severe harm, a drug is unsafe, or a patient is stable on their current medication. Plans must respond to requests within 72 hours (or 24 hours in emergencies) and cover the requested drug without extra cost-sharing. The bill also requires annual reports to the government on exception requests, approvals, denials, and trends by medical condition or specialty. This directly affects patients on health plans with step therapy, their doctors, and the insurers managing those plans.
This bill prohibits public colleges and universities receiving federal funding from denying religious student groups access to campus facilities or official recognition solely because of their religious beliefs, practices, or standards. It directly affects public higher education institutions and religious student organizations seeking equal treatment alongside secular groups. The key mechanism requires institutions to provide religious groups with the same rights, benefits, and privileges - such as meeting space, event scheduling, and official status - as non-religious student organizations. This policy change ensures religious groups cannot be discriminated against in campus activities through the threat of withheld federal funding.
The Supporting Our Seniors Act establishes a 12-member Commission on Long-Term Care to study and recommend improvements to senior care systems. The Commission, appointed by the President and congressional leaders with expertise in aging, healthcare, and caregiving, will issue annual recommendations on key issues like affordable long-term care coverage, support for family caregivers, home-based services, and access to comprehensive geriatric care. Federal agencies must respond to these recommendations within six months of receipt. The Commission will operate for 10 years, focusing on concrete policy changes to better serve seniors and their families.
S 2287, the Palliative Care and Hospice Education and Training Act, establishes federal funding to expand training for health professionals in palliative and hospice care. The bill creates multiple programs including grants for education programs, fellowships for faculty to gain specialized training, and career incentive awards for students pursuing palliative care specialties. It prioritizes training in rural and underserved areas, for pediatric populations, and for racial and ethnic minorities. The bill authorizes $15 million annually through 2030 to build a more skilled palliative care workforce for patients with serious or life-threatening illnesses.
The MAPS Act requires the Secretary of Health and Human Services to update and maintain an Essential Medicines List including drugs critical for national security, public health emergencies, chronic conditions, and military readiness. It mandates annual risk assessments identifying supply chain vulnerabilities, particularly drugs sourced over 50% from high-risk foreign suppliers like China, and compiles data on manufacturing locations and shortages. The bill directs HHS to map U.S. pharmaceutical supply chains from raw materials to finished products, using data analytics to identify national security threats, and report findings annually to Congress. This directly affects federal agencies (HHS, Defense), drug manufacturers, and supply chain stakeholders through mandatory reporting and transparency requirements.
This bill, the Conscience Protection Act of 2025, strengthens protections for healthcare providers and organizations that refuse to participate in certain medical procedures (including abortion, assisted suicide, and sterilization) based on religious, moral, or ethical beliefs. It creates a private right of action allowing affected entities to seek legal remedies when their conscience rights are violated, addressing a gap in current law where victims could not defend their rights in court. The bill amends the Public Health Service Act to prohibit discrimination against such healthcare entities and establishes clearer enforcement mechanisms through the Department of Health and Human Services, including administrative investigations and civil actions. It directly affects healthcare providers, hospitals, insurers, and other health-related organizations operating under federal funding. The bill aims to address inconsistent enforcement of existing conscience protections like the Weldon Amendment, which has been challenged in cases such as California's abortion coverage mandate.
This bill (S 1677, Ensuring Lasting Smiles Act) requires health insurance plans to cover medically necessary treatments for congenital anomalies or birth defects affecting the eyes, ears, teeth, mouth, or jaw. It mandates coverage for reconstructive services, dental/orthodontic care, and related treatments during the course of medical treatment, while excluding purely cosmetic procedures not medically necessary. Plans may apply cost-sharing requirements similar to those for other medical services but must provide notice about these coverage requirements to participants by January 1, 2026. The bill also directs a study on provider network adequacy and cost impacts related to these coverage requirements, to be completed by December 2027.
Resident Education Deferred Interest Act or the REDI Act This bill allows borrowers in medical or dental internships or residency programs to defer student loan payments until the completion of their programs.
The HELP Copays Act requires that financial assistance from non-profit organizations or prescription drug manufacturers counts toward patients' annual out-of-pocket cost-sharing limits (like deductibles and copays) for certain prescription drugs. It directly affects individuals enrolled in group health plans or individual insurance who receive such assistance, ensuring payments from these sources reduce their total out-of-pocket spending. The bill amends key healthcare laws to include these payments in calculating cost-sharing thresholds, specifically for specialty drugs and drugs subject to utilization management (like prior authorization). It takes effect for plan years beginning in 2026 and does not change how utilization management tools are applied.
This bill requires health insurance plans to cover prostate cancer screenings without copays or deductibles for men aged 40+ who are at high risk of prostate cancer. It specifically applies to African-American men and men with a family history of prostate cancer (defined as having a first-degree relative diagnosed with the disease or genetic risk factors). The law amends existing coverage requirements to include these screenings as a preventive service, aiming to address disparities in late-stage diagnosis and improve early detection rates. The policy change takes effect for plan years beginning January 1, 2025.
HR 556, the Protecting Access for Hunters and Anglers Act, prevents federal agencies from banning lead ammunition or tackle on public lands and waters managed for hunting or fishing. It directly affects hunters and anglers using federal lands (like national wildlife refuges, public forests, and BLM lands) by blocking nationwide restrictions on lead products. The bill allows limited exceptions only for specific locations where wildlife decline is directly linked to lead use, and the restriction must align with state law or get approval from the state wildlife agency. This changes how federal land managers can regulate lead, requiring state coordination for any local restrictions.
